Monoclonal antibody treatments have many challenges — Narval is fixing them
Monoclonal antibodies are the building blocks of some of the most important medical treatments in the world. But they have ...
Tag: antibody
Aridis shares plunge ~25% as antibody drug fails Phase 3 trial in pneumonia
gorodenkoff Aridis Pharmaceuticals (NASDAQ:ARDS) AR-301 monoclonal antibody therapy failed the primary endpoint in a phase 3 trial to treat ventilator-associated ...
Recommended.
